Searched for
NAMIT
HealthQuad raises Rs 550 crore, eyes Rs 1,700 crore fundHealthQuad has secured Rs 550 crore for its third fund. The venture capital firm aims to raise Rs 1,700 crore to back early-growth companie...- API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
- Prime Focus shares hit 5% upper circuit as Sebi halts proceedings in misleading financials casePrime Focus shares were locked in 5% upper circuit after Sebi closed its investigation. The market regulator found the company used correct...
- Sebi drops proceedings against Prime Focus in misleading financials caseSebi has closed adjudication proceedings against Prime Focus and its directors, ruling that the company correctly accounted for business tr...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- Ranbir Kapoor-backed Prime Focus shares gain 2% after firm returns to black with Rs 82 crore net profit in Q4Prime Focus shares saw a rise on Friday. The company reported a profit of Rs 82 crore for the fourth quarter of FY26. This marks a signific...
- Rising input costs, export slump take a toll on drug companies' healthAccording to industry executives, the modest price hike of 0.6% that the government has allowed on essential medicines effective April 1 is...
- NCLT admits insolvency plea against Prime Focus over Rs 353.79 crore claim, company challenges order in NCLATThe National Company Law Tribunal has admitted an insolvency petition against Prime Focus Ltd. Reliance Alpha Services Pvt Ltd filed the pe...
- Pharma exports surpass $31 billion in FY26 despite global headwindsIndian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Zen Mobility and Delhivery announce EV partnership for pan-India deploymentA long-term partnership to deploy thousands of purpose-built EVs pan-India over the next 3–5 years, building on 500+ vehicles already opera...
- Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firmsIndia’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...
- Iran conflict: Pharma supply chains may take months to recoverExperts said supply chains disrupted by the conflict will take months to stabilise, and prices of active pharmaceutical ingredients (APIs)-...
- 'Ramayana' impact: Ranbir Kapoor-backed smallcap stock rallies 320% in one year, should you buy?Prime Focus shares have surged over 320% in a year, fueled by excitement for Ranbir Kapoor's upcoming 'Ramayana' film. The production house...
- Ramayana teaser reviews: Ranbir Kapoor's Lord Rama glimpse gets mixed reactions, fans say 'disappointing, slightly better than Adipurush'Ramayana teaser reviews: The teaser of Ramayana movie was unveiled today in which Ranbir Kapoor's portrayal of Lord Rama has taken the inte...
- Ramayana teaser release and early reviews: Check when you can watch a glimpse of Ranbir Kapoor’s ‘Rama’ on Hanuman JayantiRamayana Teaser Time: The highly anticipated teaser for 'Ramayana,' starring Ranbir Kapoor as Lord Rama, has been released today by the mak...
- Ranbir Kapoor’s Ramayana release date update: When to watch Nitesh Tiwari’s film in the theatresNitesh Tiwari's 'Ramayana,' starring Ranbir Kapoor as Lord Rama, is generating significant buzz with its teaser screened in Los Angeles. Th...
- Sadhguru questions Yash’s casting as Ravana in Nitesh Tiwari's 'Ramayana', says “he’s too handsome”; Producer explains the choiceSpiritual leader Sadhguru Jaggi Vasudev shared his thoughts on Yash playing Ravana in Nitesh Tiwari's 'Ramayana'. He found the actor too ha...
- From Mumbai garage to 8 Oscar-winning empire: Meet Namit Malhotra, the producer of the most expensive Indian film, Ramayana. His education, careerNamit Malhotra, son of filmmaker Naresh Malhotra, is producing Ramayana. The film has a budget of ₹835 crore. The cast includes Ranbir Kapo...
- Ramayana producer Namit Malhotra shares his journey from editing in a garage to winning 8 OscarsNamit Malhotra, from a film lineage, is the producer behind the ambitious ₹835 crore Ramayana adaptation, directed by Nitesh Tiwari. Despit...
Load More
